5/21/20 16:31 | 5/20/20 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Balthrop Patrick J | X0 | D | | P | 50 | 12.48 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
5/12/20 16:49 | 5/8/20 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | P.m | 499 | 11.46 | 0 | 44 | 12 | 400 | D | | | | | | | | | | | | | | |
3/13/20 16:32 | 3/12/20 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Randall Patricia | X0 | D | | M.d | 1 | 0.0900 | 0 | 15 | 174 | 24 | D | | | | | | | | | | | | | | |
11/5/19 16:02 | 11/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.d | -47 | 15.60 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
11/5/19 16:02 | 11/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | M.d | 12 | 3.94 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
10/3/19 16:01 | 10/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S | -486 | 16.21 | 0 | -30 | -9 | 295 | D | | | | | | | | | | | | | | |
9/25/19 16:00 | 9/23/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.m | -1,659 | 16.59 | 0 | -100 | -24 | 325 | D | | | | | | | | | | | | | | |
8/20/19 16:32 | 8/16/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S | -139 | 13.86 | 0 | -10 | -2 | 425 | D | | | | | | | | | | | | | | |
8/5/19 19:43 | 8/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.a | -39 | 12.90 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
8/5/19 16:30 | 8/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -60 | 19.90 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
5/3/19 16:31 | 5/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -48 | 16.05 | 0 | -3 | -50 | 3 | D | | | | | | | | | | | | | | |
4/3/19 16:30 | 4/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -177 | 16.68 | 0 | -11 | -2 | 435 | D | | | | | | | | | | | | | | |
3/6/19 16:30 | 3/4/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | S | -70 | 17.00 | 0 | -4 | -13 | 27 | D | | | | | | | | | | | | | | |
2/20/19 16:30 | 2/19/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S | -170 | 16.99 | 0 | -10 | -2 | 413 | D | | | | | | | | | | | | | | |
2/1/19 16:30 | 2/1/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -43 | 14.25 | 0 | -3 | -33 | 6 | D | | | | | | | | | | | | | | |
1/11/19 16:35 | 1/10/19 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S | -149 | 14.91 | 0 | -10 | -2 | 423 | D | | | | | | | | | | | | | | |
11/1/18 16:30 | 11/1/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -47 | 15.50 | 0 | -3 | -25 | 9 | D | | | | | | | | | | | | | | |
10/3/18 16:30 | 10/1/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.m | -334 | 16.71 | 0 | -20 | -4 | 433 | D | | | | | | | | | | | | | | |
9/27/18 16:30 | 9/25/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 44 | 0.8100 | 0 | 54 | 14 | 453 | D | | | | | | | | | | | | | | |
9/27/18 16:30 | 9/25/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -1,586 | 18.42 | 0 | -86 | -16 | 453 | D | | | | | | | | | | | | | | |
9/10/18 16:30 | 9/7/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -598 | 14.95 | 0 | -40 | -8 | 485 | D | | | | | | | | | | | | | | |
9/10/18 16:30 | 9/7/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 32 | 0.8100 | 0 | 40 | 9 | 485 | D | | | | | | | | | | | | | | |
8/3/18 16:30 | 8/1/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -39 | 13.15 | 0 | -3 | -20 | 12 | D | | | | | | | | | | | | | | |
5/2/18 16:30 | 5/1/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.d | -38 | 12.77 | 0 | -3 | -17 | 15 | D | | | | | | | | | | | | | | |
5/2/18 16:30 | 5/1/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | M.d | 0 | 0.0900 | 0 | 3 | 25 | 15 | D | | | | | | | | | | | | | | |
2/16/18 16:30 | 2/15/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.dm | -36 | 12.01 | 0 | -3 | -17 | 15 | D | | | | | | | | | | | | | | |
2/16/18 16:30 | 2/15/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | M.dm | 0 | 0.0900 | 0 | 3 | 25 | 15 | D | | | | | | | | | | | | | | |
1/26/18 16:30 | 1/24/18 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Altieri Richard M. | X0 | O | CFO | M.d | 27 | 0.1800 | 0 | 152 | 301 | 203 | D | | | | | | | | | | | | | | |
11/2/17 16:30 | 11/1/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.d | -40 | 13.35 | 0 | -3 | -17 | 15 | D | | | | | | | | | | | | | | |
11/2/17 16:30 | 11/1/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | M.d | 2 | 0.7567 | 0 | 3 | 25 | 15 | D | | | | | | | | | | | | | | |
10/4/17 16:30 | 10/2/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -923 | 16.78 | 0 | -55 | -11 | 462 | D | | | | | | | | | | | | | | |
10/4/17 16:30 | 10/2/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 45 | 0.8100 | 0 | 55 | 14 | 462 | D | | | | | | | | | | | | | | |
9/5/17 16:30 | 9/1/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.d | -47 | 15.82 | 0 | -3 | -17 | 15 | D | | | | | | | | | | | | | | |
9/5/17 16:30 | 9/1/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | M.d | 2 | 0.8100 | 0 | 3 | 25 | 15 | D | | | | | | | | | | | | | | |
8/24/17 16:30 | 8/15/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | S.a | -157 | 16.14 | 0 | -10 | -9 | 93 | D | | | | | | | | | | | | | | |
8/16/17 16:30 | 8/15/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | S | -157 | 16.14 | 0 | -10 | -9 | 93 | D | | | | | | | | | | | | | | |
8/9/17 16:30 | 8/7/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | S | -396 | 17.70 | 0 | -22 | -18 | 103 | D | | | | | | | | | | | | | | |
7/10/17 16:30 | 7/6/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -433 | 15.94 | 0 | -27 | -6 | 462 | D | | | | | | | | | | | | | | |
7/10/17 16:30 | 7/6/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 22 | 0.8100 | 0 | 27 | 6 | 462 | D | | | | | | | | | | | | | | |
7/7/17 16:30 | 7/5/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -544 | 16.58 | 0 | -33 | -7 | 462 | D | | | | | | | | | | | | | | |
7/7/17 16:30 | 7/5/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 27 | 0.8100 | 0 | 33 | 8 | 462 | D | | | | | | | | | | | | | | |
6/29/17 16:30 | 6/28/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -482 | 16.06 | 0 | -30 | -6 | 462 | D | | | | | | | | | | | | | | |
6/29/17 16:30 | 6/28/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 24 | 0.8100 | 0 | 30 | 7 | 462 | D | | | | | | | | | | | | | | |
6/16/17 16:32 | 6/15/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | S | -61 | 15.01 | 0 | -4 | -14 | 25 | D | | | | | | | | | | | | | | |
5/16/17 17:00 | 5/15/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | S | -147 | 14.66 | 2 | -10 | -7 | 125 | D | 18 | 48 | 2 | 8 | -6 | -6 | 0 | 0 | | | | | | |
5/11/17 17:10 | 5/10/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S.d | -43 | 14.40 | 2 | -3 | -15 | 17 | D | 14 | 39 | 2 | 8 | -6 | -6 | -5 | 2 | 0 | | | | | |
5/11/17 17:10 | 5/10/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | M.d | 2 | 0.8100 | 2 | 3 | 21 | 17 | D | 14 | 39 | 2 | 8 | -6 | -6 | -5 | 2 | 0 | | | | | |
5/10/17 16:30 | 5/8/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | S.m | -566 | 14.14 | 2 | -40 | -24 | 127 | D | 14 | 40 | 4 | 9 | -6 | -6 | -6 | 2 | 0 | | | | | |
5/10/17 16:30 | 5/8/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | S.m | -566 | 14.14 | 2 | -40 | -24 | 127 | D | 14 | 40 | 4 | 9 | -6 | -6 | -6 | 2 | 0 | | | | | |
4/21/17 16:30 | 4/21/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | M.d | 11 | 0.1321 | 1 | 87 | 180 | 135 | D | 15 | 44 | 20 | 15 | 4 | 0 | 0 | 0 | 0 | 0 | | | | |
4/5/17 16:30 | 4/4/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | M.d | 6 | 0.0900 | 2 | 65 | 64 | 167 | D | 18 | 42 | 19 | 4 | 15 | 2 | -1 | -1 | 0 | 1 | -7 | | | |
4/5/17 16:29 | 4/3/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -463 | 15.43 | 2 | -30 | -6 | 462 | D | 18 | 42 | 19 | 4 | 15 | 2 | -1 | -1 | 0 | 1 | -7 | | | |
4/5/17 16:29 | 4/3/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 24 | 0.8100 | 2 | 30 | 7 | 462 | D | 18 | 42 | 19 | 4 | 15 | 2 | -1 | -1 | 0 | 1 | -7 | | | |
4/5/17 16:29 | 4/3/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -46 | 15.47 | 2 | -3 | -15 | 17 | D | 18 | 42 | 19 | 4 | 15 | 2 | -1 | -1 | 0 | 1 | -7 | | | |
3/22/17 16:59 | 3/20/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | S.d | -48 | 16.05 | 2 | -3 | -9 | 31 | D | 7 | 50 | 28 | 2 | 15 | 4 | 3 | 0 | 0 | 0 | 0 | | | |
3/22/17 16:59 | 3/20/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | M.d | 9 | 0.8100 | 2 | 11 | 58 | 31 | D | 7 | 50 | 28 | 2 | 15 | 4 | 3 | 0 | 0 | 0 | 0 | | | |
3/6/17 17:00 | 3/3/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | S.d | -88 | 14.92 | 2 | -6 | -11 | 48 | D | 5 | 51 | 45 | 2 | 11 | 12 | 13 | 11 | 0 | 0 | 3 | | | |
2/7/17 18:29 | 2/6/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -334 | 13.36 | 1 | -25 | -5 | 438 | D | 3 | 34 | 38 | -4 | -10 | 0 | -1 | -1 | 1 | 1 | 12 | 5 | | |
2/7/17 18:29 | 2/6/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 20 | 0.8100 | 1 | 25 | 6 | 438 | D | 3 | 34 | 38 | -4 | -10 | 0 | -1 | -1 | 1 | 1 | 12 | 5 | | |
1/4/17 16:30 | 1/3/17 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | M.d | 3 | 0.0900 | 1 | 36 | 63 | 93 | D | 8 | 35 | 66 | 15 | 1 | -2 | -1 | 0 | -1 | -2 | -10 | 3 | | |
12/20/16 16:30 | 12/16/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -106 | 15.07 | 1 | -7 | -2 | 443 | D | 24 | 25 | 68 | 24 | 4 | 1 | 1 | 2 | -1 | -1 | -10 | 3 | | |
12/20/16 16:30 | 12/16/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 6 | 0.8100 | 1 | 7 | 2 | 443 | D | 24 | 25 | 68 | 24 | 4 | 1 | 1 | 2 | -1 | -1 | -10 | 3 | | |
12/7/16 17:11 | 12/5/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.d | -17 | 15.00 | 1 | -1 | 0 | 443 | D | 25 | 12 | 65 | 36 | 15 | 3 | 2 | -1 | 5 | 6 | 6 | 6 | | |
12/7/16 17:11 | 12/5/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.d | 1 | 0.8100 | 1 | 1 | 0 | 443 | D | 25 | 12 | 65 | 36 | 15 | 3 | 2 | -1 | 5 | 6 | 6 | 6 | | |
12/5/16 16:31 | 12/1/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | S.dm | -927 | 15.00 | 1 | -62 | -12 | 443 | D | 15 | 18 | 64 | 40 | 15 | 4 | 2 | 1 | -1 | 0 | 0 | 0 | | |
12/5/16 16:31 | 12/1/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Wrighton-Smith Peter | X0 | DO | CEO | M.dm | 17 | 0.8100 | 1 | 21 | 5 | 443 | D | 15 | 18 | 64 | 40 | 15 | 4 | 2 | 1 | -1 | 0 | 0 | 0 | | |
11/16/16 16:01 | 11/8/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Edwardson Peter | X0 | O | Chief Op | S | -69 | 14.09 | 1 | -5 | -9 | 49 | D | 1 | 12 | 58 | 51 | 11 | 14 | 4 | 2 | -1 | 0 | 3 | -8 | | |
11/9/16 16:41 | 11/8/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -170 | 14.17 | 1 | -12 | -37 | 20 | D | -3 | 18 | 44 | 51 | 16 | 9 | 9 | 2 | -1 | 1 | 3 | -6 | 2 | |
1/19/16 17:06 | 1/15/16 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Randall Patricia | X0 | D | | M.d | 0 | 0.0900 | 0 | 5 | 137 | 9 | D | -47 | -27 | -25 | -15 | -18 | -12 | -5 | -1 | 5 | 9 | -2 | 6 | -13 | 29 |
11/20/15 14:32 | 11/18/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -67 | 13.48 | 1 | -5 | -13 | 32 | D | | 2 | -1 | 4 | 10 | 8 | 10 | 5 | 1 | -2 | -12 | -28 | -33 | 8 |
11/19/15 14:10 | 11/17/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -65 | 13.00 | 1 | -5 | -12 | 37 | D | | -2 | -1 | 7 | 12 | 12 | 12 | 8 | 1 | 0 | -11 | -27 | -34 | 8 |
8/5/15 11:58 | 8/4/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -42 | 14.00 | 1 | -3 | -7 | 42 | D | | -17 | 13 | 16 | -2 | 4 | 1 | 7 | 0 | -5 | 6 | -9 | -22 | -30 |
6/17/15 16:54 | 6/15/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Clarus Lifesciences I, L.P. | MA | T | | S.m | -590 | 14.30 | 1 | -41 | -2 | 2,237 | D | | -22 | 29 | -3 | 17 | 7 | 0 | -1 | 0 | 0 | -6 | 1 | -16 | -34 |
6/12/15 16:58 | 6/11/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Clarus Lifesciences I, L.P. | MA | T | | S.m | -451 | 14.27 | 1 | -32 | -1 | 2,279 | D | | -16 | 21 | 0 | 8 | 6 | 0 | 0 | 0 | 1 | -6 | 1 | -10 | -37 |
6/10/15 19:02 | 6/8/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Clarus Lifesciences I, L.P. | MA | T | | S.m | -352 | 14.28 | 1 | -25 | -1 | 2,310 | D | | -17 | 20 | 3 | 5 | 10 | 3 | 2 | 0 | -1 | -12 | -2 | -8 | -38 |
6/3/15 17:21 | 6/1/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Clarus Lifesciences I, L.P. | MA | T | | S.m | -521 | 14.29 | 1 | -36 | -2 | 2,335 | D | | -15 | 9 | 0 | 5 | 14 | 6 | 9 | -3 | -1 | -10 | 0 | -7 | -36 |
6/2/15 16:55 | 6/1/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -42 | 14.14 | 1 | -3 | -6 | 45 | D | | -18 | 7 | -1 | 4 | 12 | 6 | 8 | 0 | 0 | -3 | -1 | -7 | -38 |
3/24/15 17:20 | 3/20/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Clarus Lifesciences I, L.P. | MA | T | | S.m | -774 | 14.49 | 2 | -53 | -2 | 2,371 | D | | -31 | -1 | 18 | 10 | -1 | -2 | -4 | -6 | -6 | -4 | 1 | 0 | -31 |
3/19/15 17:44 | 3/17/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Clarus Lifesciences I, L.P. | MA | T | | S.m | -2,261 | 14.65 | 1 | -154 | -6 | 2,425 | D | | -36 | 3 | 37 | 17 | 4 | 7 | 4 | -1 | -9 | -7 | -2 | 2 | -31 |
1/16/15 10:58 | 1/14/15 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandberg Richard A | X0 | D | | S | -42 | 14.00 | 1 | -3 | -6 | 48 | D | | -27 | -14 | -5 | 10 | 13 | 10 | 5 | 3 | -1 | -9 | -5 | -3 | -27 |
12/8/14 16:15 | 12/4/14 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Randall Patricia | X0 | D | | S.m | -60 | 12.06 | 0 | -5 | -58 | 4 | D | | -34 | -30 | -21 | -20 | -17 | -6 | -8 | -1 | -8 | 8 | 16 | 19 | 11 |
1/24/14 15:40 | 1/22/14 | OXFD | Health | Diagn | In Vitro & In Vivo Diagnostic | Randall Patricia | X0 | O | VP,GC | M.d | 1 | 0.0900 | 1 | 9 | New | 9 | D | | | | | 18 | 14 | 16 | 10 | -2 | -4 | 6 | -18 | -25 | -35 |